Fairfield, Bush & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,565
| Closed | -$9.37K | – | 140 |
|
|
2023
Q4 | $9.37K | Buy |
+1,565
| New | +$9.37K | 0.01% | 309 |
|
|
2023
Q3 | – | Sell |
-1,565
| Closed | -$11K | – | 136 |
|
|
2023
Q2 | $11K | Buy |
+1,565
| New | +$11K | ﹤0.01% | 314 |
|
|
2022
Q3 | – | Sell |
-2,065
| Closed | -$22K | – | 141 |
|
|
2022
Q2 | $22K | Buy |
+2,065
| New | +$22K | 0.01% | 247 |
|